Metagenomi, Inc. Common Stock
MGX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $8,659 | $8,513 | $4,127 | $9,614 |
| % Growth | 1.7% | 106.3% | -57.1% | – |
| Cost of Goods Sold | $1,324 | $22,507 | $0 | $0 |
| Gross Profit | $7,335 | -$13,994 | $4,127 | $9,614 |
| % Margin | 84.7% | -164.4% | 100% | 100% |
| R&D Expenses | $23,959 | $22,507 | $25,142 | $23,164 |
| G&A Expenses | $0 | $6,993 | $6,805 | $7,073 |
| SG&A Expenses | $6,215 | $6,993 | $6,805 | $7,073 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$22,507 | $0 | $0 |
| Operating Expenses | $30,174 | $6,993 | $31,947 | $30,237 |
| Operating Income | -$22,839 | -$20,987 | -$27,820 | -$20,623 |
| % Margin | -263.8% | -246.5% | -674.1% | -214.5% |
| Other Income/Exp. Net | $2,212 | $1,123 | $2,879 | -$3,983 |
| Pre-Tax Income | -$20,627 | -$19,864 | -$24,941 | -$24,606 |
| Tax Expense | -$234 | $44 | $98 | -$1,208 |
| Net Income | -$20,393 | -$19,908 | -$25,039 | -$23,398 |
| % Margin | -235.5% | -233.9% | -606.7% | -243.4% |
| EPS | -0.55 | -0.54 | -0.68 | -0.63 |
| % Growth | -1.9% | 20.6% | -7.9% | – |
| EPS Diluted | -0.55 | -0.54 | -0.68 | -0.63 |
| Weighted Avg Shares Out | 37,349 | 37,157 | 37,019 | 37,092 |
| Weighted Avg Shares Out Dil | 37,349 | 37,157 | 37,019 | 37,092 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,214 | $2,485 | $2,887 | $3,196 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1,324 | $1,335 | $1,358 | $1,461 |
| EBITDA | -$19,303 | -$19,652 | -$26,462 | -$19,162 |
| % Margin | -222.9% | -230.8% | -641.2% | -199.3% |